StratExecutive Summary
Profit is an outcome, not a diagnosis.
No source code required.
This is not investment advice.
This is a fictional demo for product demonstration only.
StratVitals Strategy Health Quick Report
Sample Strategy Health Quick Report
A fictional demo showing how StratVitals summarizes behavior evidence, risk flags, and next-step diagnosis without requiring source code.
Submitted Strategy Profile
Strategy Name
Demo Breakout Strategy
Strategy Type
Breakout
Market / Symbol
BTCUSDT
Timeframe
15m
Backtest or Trading Period
2024-01-01 to 2025-12-31
Total Trades
128
Total Profit
+34.8%
Max Drawdown
-18.6%
Fee Setting
0.04% per side
Data Completeness Check
Data coverage Partial gaps detected around volatile sessions.
Sample size Usable for an initial review, but not enough for final production confidence.
Fee impact Fee drag may materially reduce reported profit after execution costs.
Drawdown behavior Peak-to-trough pressure requires manual review before live-readiness decisions.
Strategy Health Quick Score
The demo strategy receives 61 / 100, which indicates the strategy may be worth deeper review but should not be treated as live-ready from profit alone.
Suggested Next Step: Focused Strategy Health Diagnosis
Risk Flags
Drawdown RiskFee Impact RiskMissing Data Risk
These flags are preliminary and based on behavior evidence from the submitted report, not hidden rules or proprietary source code.
Preliminary Diagnosis
The strategy shows positive total profit, but drawdown pressure, fee sensitivity, and possible missing data reduce confidence in production readiness.
The next diagnosis should inspect trade distribution, worst-loss clusters, fee-adjusted profit, and whether the breakout entries degrade during sideways periods.
Recommended Next Steps
Move from a Standard Strategy Health Quick Check to a Focused Strategy Health Diagnosis before allocating real capital.
The focused review can examine MAE / MFE, Signal Log quality, execution assumptions, sample gaps, and live-readiness risk.
Privacy Note
The first-layer quick report does not require source code. StratVitals can review exported backtest summaries, trade logs, signal logs, risk metrics, and anonymized evidence while keeping proprietary strategy logic private.
Disclaimer
StratVitals is designed for historical data research, strategy risk diagnosis, backtest quality review, and educational analysis. It does not provide investment advice, financial advice, trading signals, copy trading, account management, or profit guarantees.
This sample report uses fictional demo data for product demonstration only.